Resmed Inc DRC (RSMDF)

OTC Markets
Currency in USD
21.70
0.00(0.00%)
Delayed Data
RSMDF Scorecard
Full Analysis
Has raised its dividend for 13 consecutive years
Earnings results expected in 8 days
Fair Value
Day's Range
21.7021.70
52 wk Range
17.7024.55
Key Statistics
Edit
Prev. Close
21.7
Open
21.7
Day's Range
21.7-21.7
52 wk Range
17.7-24.55
Volume
-
Average Volume (3m)
2.2K
1-Year Change
33.7%
Book Value / Share
35.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RSMDF Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Resmed Inc DRC Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Compare RSMDF to Peers and Sector

Metrics to compare
RSMDF
Peers
Sector
Relationship
P/E Ratio
32.7x58.7x−0.6x
PEG Ratio
1.40−2.070.00
Price/Book
7.0x8.1x2.6x
Price / LTM Sales
7.6x11.4x3.1x
Upside (Analyst Target)
-23.2%50.2%
Fair Value Upside
Unlock−29.2%7.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.57
Dividend Yield
-
Annualized payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 24, 2024
EPS / Forecast
0.22 / 0.2056
Revenue / Forecast
1.22B / 1.19B
EPS Revisions
Last 90 days

People Also Watch

270.25
CSL
-1.16%
100.64
JBH
+2.68%
10.640
TWE
-1.12%
25.250
WDS
-1.87%
13.720
TCL
+0.22%

FAQ

What Is the Resmed DRC (RSMDF) Stock Price Today?

The Resmed DRC stock price today is 21.70

What Stock Exchange Does Resmed DRC Trade On?

Resmed DRC is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Resmed DRC?

The stock symbol for Resmed DRC is "RSMDF."

What Is the Resmed DRC Market Cap?

As of today, Resmed DRC market cap is 36.45B.

What is Resmed DRC Earnings Per Share?

The Resmed DRC EPS is 7.57.

What Is the Next Resmed DRC Earnings Date?

Resmed DRC will release its next earnings report on Jan 29, 2025.

From a Technical Analysis Perspective, Is RSMDF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.